Showing results (41-50 of 204) with videos related to

Sort By:
Pageof 21
Scientific Reports|August 7, 2025
Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulationsMohd Shahnawaz Khan, Anas Shamsi, Moyad Shahwan, et al.
Frontiers in Cellular Neuroscience|December 10, 2025
Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disordersAnas Shamsi, Mohammed Alrouji, Othman AlOmeir, et al.
Plos One|February 6, 2025
Identification and prioritization of novel therapeutic candidates against glutamate racemase from Klebsiella pneumoniaeAnkit Kumar, Farah Anjum, Md Imtaiyaz Hassan, et al.
ACS Omega|May 31, 2021
Insight into the In Vitro Antiglycation and In Vivo Antidiabetic Effects of Thiamine: Implications of Vitamin B1 in Controlling DiabetesK M Abdullah, Afrah Arefeen, Anas Shamsi, et al.
International Journal of Biological Macromolecules|June 12, 2020
Rosmarinic acid restrains protein glycation and aggregation in human serum albumin: Multi spectroscopic and microscopic insight - Possible Therapeutics Targeting DiseasesAnas Shamsi, Azaj Ahmed, Mohd Shahnawaz Khan, et al.
Nutrients|September 14, 2024
Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative ReviewBhoomika Sharma, Chitra Dhiman, Gulam Mustafa Hasan, et al.
Scientific Reports|May 4, 2025
Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancerSaleha Anwar, Mohd Shahnawaz Khan, Dharmendra Kumar Yadav, et al.
Journal of Personalized Medicine|April 27, 2024
Elucidating the Impact of Deleterious Mutations on IGHG1 and Their Association with Huntington's DiseaseAlaa Shafie, Amal Adnan Ashour, Farah Anjum, et al.
Fitoterapia|January 3, 2024
Insights into the preventive actions of natural compounds against Klebsiella pneumoniae infections and drug resistanceSana Saifi, Anam Ashraf, Gulam Mustafa Hasan, et al.
Frontiers in Cellular Neuroscience|November 3, 2025
CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disordersAnas Shamsi, Mohammed Alrouji, Othman AlOmeir, et al.
Pageof 21